| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
42,414 |
33,307 |
$1.91M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
8,268 |
6,552 |
$516K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
8,542 |
7,286 |
$510K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
8,983 |
7,782 |
$505K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
7,036 |
5,848 |
$464K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,988 |
4,231 |
$364K |
| 90686 |
|
12,942 |
10,810 |
$151K |
| 92551 |
|
16,679 |
14,191 |
$108K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
4,208 |
3,648 |
$108K |
| 99381 |
|
1,188 |
913 |
$87K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
15,034 |
12,923 |
$67K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
7,024 |
5,991 |
$63K |
| 90670 |
|
4,786 |
4,045 |
$58K |
| 99401 |
|
6,165 |
4,550 |
$54K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,768 |
2,019 |
$46K |
| 90697 |
|
2,119 |
1,638 |
$45K |
| 90680 |
|
3,481 |
2,918 |
$42K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,638 |
1,083 |
$40K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,301 |
963 |
$35K |
| 90647 |
|
3,010 |
2,696 |
$32K |
| 90633 |
|
2,393 |
2,020 |
$32K |
| 99173 |
|
18,056 |
15,282 |
$28K |
| 90651 |
|
2,266 |
1,986 |
$24K |
| 90723 |
|
1,993 |
1,834 |
$22K |
| 90620 |
|
1,473 |
1,204 |
$22K |
| 0001A |
|
658 |
520 |
$19K |
| 99174 |
|
4,893 |
4,139 |
$19K |
| 0002A |
|
630 |
501 |
$19K |
| 90734 |
|
1,540 |
1,312 |
$17K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
1,314 |
1,142 |
$17K |
| 96127 |
|
4,141 |
3,673 |
$16K |
| 96160 |
|
6,189 |
5,067 |
$15K |
| 90656 |
|
758 |
744 |
$14K |
| 90677 |
|
679 |
604 |
$12K |
| 90707 |
|
841 |
705 |
$12K |
| 90715 |
|
1,010 |
849 |
$12K |
| 90716 |
|
840 |
703 |
$11K |
| 0071A |
|
492 |
331 |
$11K |
| 90619 |
|
637 |
474 |
$11K |
| 90700 |
|
805 |
667 |
$10K |
| 90710 |
|
772 |
624 |
$10K |
| 0072A |
|
345 |
284 |
$10K |
| 83655 |
|
1,627 |
1,447 |
$9K |
| 90696 |
|
707 |
581 |
$9K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,423 |
1,077 |
$8K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
221 |
183 |
$7K |
| 90672 |
|
526 |
327 |
$6K |
| 90681 |
|
407 |
347 |
$6K |
| 0003A |
|
201 |
161 |
$5K |
| 99188 |
|
352 |
272 |
$3K |
| Q3014 |
Telehealth originating site facility fee |
712 |
647 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
1,646 |
1,458 |
$2K |
| 87807 |
|
417 |
382 |
$2K |
| 85018 |
|
837 |
744 |
$999.68 |
| 0073A |
|
26 |
24 |
$920.00 |
| 0124A |
|
92 |
33 |
$640.00 |
| 97802 |
|
505 |
478 |
$594.00 |
| 90674 |
|
117 |
109 |
$521.14 |
| 81002 |
|
708 |
638 |
$517.35 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
33 |
33 |
$473.96 |
| A7004 |
Small volume nonfiltered pneumatic nebulizer, disposable |
600 |
379 |
$454.43 |
| 0111A |
|
14 |
12 |
$440.00 |
| 90660 |
|
19 |
19 |
$375.19 |
| 90621 |
|
139 |
99 |
$308.98 |
| 0081A |
|
20 |
14 |
$280.00 |
| 99000 |
|
86 |
65 |
$81.90 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
988 |
797 |
$32.33 |
| 86580 |
|
15 |
15 |
$5.00 |
| 91307 |
|
932 |
639 |
$2.25 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
397 |
394 |
$0.00 |
| 90474 |
|
44 |
27 |
$0.00 |
| 36416 |
|
15 |
15 |
$0.00 |
| 90461 |
|
9,774 |
8,265 |
$0.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
25,709 |
21,847 |
$0.00 |
| 90685 |
|
130 |
112 |
$0.00 |
| 90473 |
|
387 |
230 |
$0.00 |
| 91300 |
|
1,577 |
1,147 |
$0.00 |
| 3725F |
|
397 |
394 |
$0.00 |
| 91311 |
|
22 |
20 |
$0.00 |
| 91308 |
|
40 |
33 |
$0.00 |
| 91312 |
|
31 |
16 |
$0.00 |